© Scanpix/Reuters
|
On Monday Gilead Sciences Inc. announced about the takeover of Pharmasset Inc. for $137 cash a share; the total sum being $11 billion. The share price of Pharmasset Inc. almost doubled after the announcement. Friday's closing price was $69.02. Gilead Sciences is going to finance the acquisition partly by cash on hand, partly by debt financing.